249 related articles for article (PubMed ID: 36765396)
21. Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.
Ye S; Guo Q; Tang JP; Yang CD; Shen N; Chen SL
Clin Rheumatol; 2007 Feb; 26(2):186-90. PubMed ID: 16565890
[TBL] [Abstract][Full Text] [Related]
22. Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus.
Kawasaki M; Fujishiro M; Yamaguchi A; Nozawa K; Kaneko H; Takasaki Y; Takamori K; Ogawa H; Sekigawa I
Lupus; 2011 Oct; 20(12):1231-9. PubMed ID: 21980035
[TBL] [Abstract][Full Text] [Related]
23. The exploration of shared genes and molecular mechanisms of systemic lupus erythematosus and atherosclerosis.
Fan JL; Wu D; Zhu TT; Tian XL; Liu SJ; Zhang SL
Lupus; 2023 Feb; 32(2):239-251. PubMed ID: 36480924
[TBL] [Abstract][Full Text] [Related]
24. Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus.
Kim A; Choi SJ; Song GG; Kim JH; Jung JH
Clin Rheumatol; 2023 Oct; 42(10):2799-2809. PubMed ID: 37369873
[TBL] [Abstract][Full Text] [Related]
25. The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus.
Fan W; Wei B; Chen X; Zhang Y; Xiao P; Li K; Zhang YQ; Huang J; Leng L; Bucala R
Res Sq; 2023 Sep; ():. PubMed ID: 37790522
[TBL] [Abstract][Full Text] [Related]
26. Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis.
Wang Y; Ma Q; Huo Z
Medicine (Baltimore); 2021 Jun; 100(25):e26499. PubMed ID: 34160465
[TBL] [Abstract][Full Text] [Related]
27. Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE.
Juárez-Vicuña Y; Pérez-Ramos J; Adalid-Peralta L; Sánchez F; Martínez-Martínez LA; Ortiz-Segura MDC; Pichardo-Ontiveros E; Hernández-Díazcouder A; Amezcua-Guerra LM; Ramírez-Bello J; Sánchez-Muñoz F
Front Genet; 2021; 12():647487. PubMed ID: 34149799
[TBL] [Abstract][Full Text] [Related]
28. Comparative Analysis on Abnormal Methylome of Differentially Expressed Genes and Disease Pathways in the Immune Cells of RA and SLE.
Fang Q; Li T; Chen P; Wu Y; Wang T; Mo L; Ou J; Nandakumar KS
Front Immunol; 2021; 12():668007. PubMed ID: 34079550
[TBL] [Abstract][Full Text] [Related]
29. Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach.
Thakur K; Janjua D; Shishodia G; Chhokar A; Aggarwal N; Yadav J; Tripathi T; Chaudhary A; Senrung A; Bharti AC
Med Oncol; 2022 Oct; 39(12):255. PubMed ID: 36224441
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
Alunno A; Padjen I; Fanouriakis A; Boumpas DT
Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
[TBL] [Abstract][Full Text] [Related]
31. Immune-relevant genes of systemic lupus erythematosus by transcriptome profiling analysis.
Lv J; Chen L; Wang X; Gao Q; Zhao L
Cytokine; 2022 Oct; 158():155975. PubMed ID: 35964416
[TBL] [Abstract][Full Text] [Related]
32. Identification of EPSTI1 as a new potential biomarker for SLE based on GEO database.
Yang Y; Zhang H; Xiao X; Guo M
Clin Rheumatol; 2024 May; 43(5):1531-1540. PubMed ID: 38507132
[TBL] [Abstract][Full Text] [Related]
33. Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis.
Yu Y; Liu L; Hu LL; Yu LL; Li JP; Rao JA; Zhu LJ; Liang Q; Zhang RW; Bao HH; Cheng XS
Bioengineered; 2021 Dec; 12(1):2810-2819. PubMed ID: 34180358
[TBL] [Abstract][Full Text] [Related]
34. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
Gallucci S; Meka S; Gamero AM
Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
[TBL] [Abstract][Full Text] [Related]
35. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
Chyuan IT; Tzeng HT; Chen JY
Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
[TBL] [Abstract][Full Text] [Related]
36. HERC6 is upregulated in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and promotes the disease progression.
Cao L; Zhang H; Bai J; Wu T; Wang Y; Wang N; Huang C
Autoimmunity; 2022 Dec; 55(8):506-514. PubMed ID: 35880641
[TBL] [Abstract][Full Text] [Related]
37. Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus.
Feng X; Huang J; Liu Y; Xiao L; Wang D; Hua B; Tsao BP; Sun L
Clin Rheumatol; 2015 Jan; 34(1):71-9. PubMed ID: 25344775
[TBL] [Abstract][Full Text] [Related]
38. Decoding the mitochondrial connection: development and validation of biomarkers for classifying and treating systemic lupus erythematosus through bioinformatics and machine learning.
Li H; Zhou L; Zhou W; Zhang X; Shang J; Feng X; Yu L; Fan J; Ren J; Zhang R; Duan X
BMC Rheumatol; 2023 Dec; 7(1):44. PubMed ID: 38044432
[TBL] [Abstract][Full Text] [Related]
39. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
[TBL] [Abstract][Full Text] [Related]
40. Identification of crucial genes for predicting the risk of atherosclerosis with system lupus erythematosus based on comprehensive bioinformatics analysis and machine learning.
Liu C; Zhou Y; Zhou Y; Tang X; Tang L; Wang J
Comput Biol Med; 2023 Jan; 152():106388. PubMed ID: 36470144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
